BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 · Journal of Hepatology · 3,880 citations
https://doi.org/10.1016/j.jhep.2021.11.018
M
María Reig
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
355
Papers
26.1K
Citations
60
h-index
140
i10-index
María Reig is an academic researcher from Hospital San Juan de Dios. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Hepatitis C virus research. The author has an h-index of 60, co-authored 302 publications.
ORCID: 0000-0002-5711-9534Papers by this author
worksEASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 · Journal of Hepatology · 495 citations
https://doi.org/10.1016/j.jhep.2024.08.028
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
2020 · Journal of Hepatology · 271 citations
https://doi.org/10.1016/j.jhep.2019.10.021
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
2021 · Journal of Hepatology · 215 citations
https://doi.org/10.1016/j.jhep.2021.04.047
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
2021 · Gut · 95 citations
https://doi.org/10.1136/gutjnl-2020-323663
Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)
2021 · Journal of Hepatology · 91 citations
https://doi.org/10.1016/j.jhep.2021.01.046
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat